Is Canada ready? Routine use of genome based testing in Canada’s Major Regions. A State of Readiness Progress Report
Syantra Receives CE Mark Approval for their Breast Cancer Test Built on the Syantra DX™ Liquid Biopsy Platform
GlycoNet and partners invest $1.7M in Canadian-led health research and bioinnovation
Canada needs to invest now to address antimicrobial resistance
Alberta becomes the first province to list Trodelvy for triple-negative breast cancer
